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Apoptosis is an evolutionarily conserved form of cell suicide that
functions to eliminate damaged and unnecessary cells. Key players
involved in the apoptotic signalling network are the death receptors
which directly activate the caspase cascade via apoptotic adaptor
proteins (Ashkenazi and Dixit, 1998). In an alternative pathway,
designated the mitochondrial pathway, translocation of proapoptotic
bcl-2 family members (Bax, Bid) to the mitochondrial membrane
and subsequent outer mitochondrial membrane permeabilization
triggers release of apoptogenic factors such as cytochrome c, AIF
(apoptosis-inducing factor) and Smac/DIABLO (Liu et al, 1996;
Kroemer, 1999; Daugas et al, 2000; Du et al, 2000; Verhagen et al,
2000). In the presence of dATP, cytoplasmic cytochrome c forms a
complex with APAF-1 and pro-caspase-9 (pro-Casp9), resulting in
autocatalytic Casp9 activation (Li et al, 1997; Zou et al, 1997).
Activated Casp9 then activates executioner caspase Casp3 (Li et al,
1997). 
Recently, an increasing number of protein kinases has been
shown to be involved in regulation of apoptosis (Cross et al, 2000).
The DAP (death associated protein) kinase family is a group of pro-
apoptotic serine/threonine kinases (Inbal et al, 2000; Kögel et al,
2001). The five members of this family are DAP kinase (Deiss et al,
1995), Dlk/ZIP kinase (Kögel et al, 1998, Kawai et al, 1998), DRP-
1/DAPK2 (Kawai et al, 1999, Inbal et al, 2000), DRAK1 and
DRAK2 (Sanjo et al, 1998). Dlk/ZIP kinase is expressed in the
nervous system (Kögel et al, 1998). In non-apoptotic cells, Dlk/ZIP
kinase is located in the nucleus where it interacts with transcription
factors ATF4 and AATF (Kawai et al, 1998; Page et al, 1999a, Page
et al, 1999b). The apoptotic activity of Dlk/ZIP kinase requires its
relocation from the nucleus to the cytoplasm. One established
model for relocation of Dlk/ZIP kinase involves complex formation
of Dlk/ZIP kinase with the early apoptosis response factor Par-4
(Page et al, 1999b). However, the role of Dlk/ZIP kinase in tumour
progression and metastasis and the apoptotic signalling pathways in
which Dlk/ZIP kinase is embedded are not well understood to date.
In the present study, we have determined the expression of Dlk/ZIP
kinase and Par-4 in medulloblastoma and neuroblastoma cell lines.
Additionally, we present evidence for the requirement of the mito-
chondrial pathway in Dlk/ZIP kinase-mediated apoptosis. 
MATERIALS AND METHODS 
Chemicals 
Caspase-inhibitors Ac-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-
CHO) and Ac-Tyr-Val-Ala-Asp-aldehyde (Ac-YVAD-CHO) were
purchased from Bachem (Heidelberg, Germany), Z-Val-Ala-
Asp(O-methyl)-fluoromethylketone (zVAD-fmk) was obtained
from Enzyme Systems Products (Dublin, CA, USA). 
Semiquantitative RT-PCR 
RT-PCR was performed with Ready to Go™ RT-PCR Beads
(Amersham Pharmacia Biotech, Freiburg, Germany) according to
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medulloblastoma cell lines Daoy, D341, MHH-MED-1 and D-283
and from human neuroblastoma cell lines IMR-5, SH-SY5Y,
KCN, SHEP-SF, CH-LA-90, LA-N-6 and SK-M-FI was analysed
for expression of Dlk/ZIP kinase and Par-4, with 18S-rRNA
expression serving as an internal control. A 390 bp product of
Dlk/ZIP kinase was amplified with primers 5′ -CTACCTG-
GTCAGCTGACCCAC-3′ and 5′ -TGCTTGAGGAACTGGGT-
GGC-3′ (30 PCR cycles), and a 501 bp product of Par-4 was
amplified with primers 5′ -AGAGACCTAGATGACATAGAAG-3′
and 5′ -GGCACACATCAGTATAGGGAC-3′ (25 PCR cycles).
The 397 bp 18S rRNA product was generated with primers 5′ -
TAGTTGGTGGAGCGATTTGTC-3′ and 5′ -GGCCTCACTAAA
CCATCCAAT-3′ (20 PCR cycles). All PCR reactions were run as
follows: After the RT reaction the indicated number of PCR cycles
(1 min denaturation at 95˚C, 1 min annealing at 56˚C and 1 min
elongation at 72˚C) were performed. 
Cloning
Plasmids encoding GFP (green fluorescent protein) fusion proteins
of wild type Dlk/ZIP kinase, kinase negative mutant K42A and
deletion mutant ∆ C2 have been described previously (Kögel et al,
1999). pGFP-Bax was generated by amplifying the complete ORF
(codon 1–192) of human Bax-alpha with primers 5′ -TTAGATC-
TATGGACGGGTCCGGGGAG-3′ and 5′ -AAGAATTCCCAT-
CTTCTTCCAGATGGTGA-3′ using Pfu Polymerase (Promega,
Mannheim, Germany). The obtained PCR product was then
digested with BglII and EcoRI and cloned between the BglII and
EcoRI sites of pGFP1-C1 (Clontech, Palo Alto, CA, USA). 
Cell culture and transfection 
Generation of stable cell lines D-283 SFFV and D-283 bcl-xL
which are derived from human D-283 medulloblastoma cells has
been described previously (Poppe et al, 2001). Both cell lines were
cultured in RPMI 1640 medium (Life Technologies, Germany)
supplemented with penicillin (100 U/ml), streptomycin (100 U/ml)
and 10% fetal calf serum (Life Technologies). For immunofluores-
cence microscopy experiments cells were grown on poly-L-lysine
coated glass coverslips. For apoptosis assays cells were plated on
24-well tissue culture plates (Nunc, Hamburg, Germany) and trans-
fected with a plasmid coding for GFP-∆ C2, a constitutively pro-
apoptotic deletion mutant of Dlk/ZIP kinase (Kögel et al, 1999).
300 ng DNA and 2 µ l Lipofectamine (Gibco BRL) were diluted in
300 µ l RPMI medium under serum free conditions and incubated at
room temperature for 30 min. The cultures were incubated with the
DNA-Lipofectamine-transfection mixture at 37˚C and 5% CO2 for
2 h. Cells were then cultured with RPMI medium containing 10%
fetal calf serum. The apoptotic morphology of the cells was investi-
gated by epifluorescence microscopy using an Eclipse TE 300
inverted microscope and a 20× objective (Nikon, Düsseldorf,
Germany) equipped with the appropriate filter set (excitation of
465 to 495 nm, dichroic mirror of 505 nm and emission of 515 to
555 nm) for GFP fluorescence. For each transfection the apoptosis
stage distribution of at least 100 GFP-positive cells was scored in
triplicate. All experiments were repeated three times. 
Immunofluorescence analysis 
For immunofluorescence analysis, cells were fixed on eight-well
tissue culture slides by subsequent incubation with 2% paraformalde-
hyde in PBS at room temperature and pure methanol at –20˚C for 15
min each. After fixation the cells were washed three times with PBS,
permeabilized at 4˚C for 3 min in PBS containing 0.1% Triton X-100
and then incubated with blocking solution (PBS with 5% horse serum
and 0.3% Triton X-100) for 30 min at room temperature. Cytochrome
c was detected using a monoclonal anti-cytochrome c antibody (clone
6H2.B4; Pharmingen Becton Dickinson) which recognizes the native
form of cytochrome c. The antibody was used at a concentration of
1:1000 in PBS containing 1% horse serum and 0.3% Triton X-100.
After incubation at room temperature for 2 h, cells were washed twice
with PBS and incubated with biotin-conjugated anti-mouse IgG anti-
body (Vector Laboratories, Burlingame, CA) at a dilution of 1:500.
The second antibody was detected using Texas-Red conjugated strep-
tavidin (Molecular Probes) diluted 1:1000 in PBS for 20 min at room
temperature. Epifluorescence microscopy was observed with the
Eclipse TE 300 inverted microscope and a 40 × oil immersion objec-
tive. Texas Red fluorescence was observed with the following optics:
excitation 540–580 nm; dichroic mirror, 595 nm; emission, 600 to
660 nm. Digital images were acquired with a SPOT-2 camera using
Spot software version 2.2.1 (Diagnostic Instruments, Sterling
Heights, MI). 
RESULTS 
Expression analysis of Dlk/ZIP kinase and Par-4 in
human medulloblastoma and neuroblastoma cell lines 
Dlk/ZIP kinase expression has been demonstrated in various
tissues, including mammalian brain (Kögel et al, 1999). The
expression of Dlk/ZIP kinase was investigated by RT-PCR analysis
of neuronal tumour cell lines. Dlk/ZIP kinase was expressed in all
five medulloblastoma cell lines and in all seven neuroblastoma cell
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Figure 1 Expression of both DIk/ZIP kinase and Par-4 in human
medulloblastoma and neuroblastoma cell lines as analysed by RT-PCR.
cDNA from cultured cell lines Daoy, D341, MHH-MED-1, D-283, IMR-5, 
SH-SY5Y, KCN, SHEP-SF, CH-LA-90, LA-N-6 and SK-M-FI was amplified by
20 cycles (18S rRNA), 25 cycles (Par-4) or 30 cycles (DIk/ZIP kinase) of
PCR. Reaction products were separated by agarose gel electrophoresis and
visualized with 0.1% ethidium bromide lines tested (Figure 1A). Interestingly, significant basal expression
of the Dlk/ZIP kinase interaction partner Par-4 is observed in only
one of the neuroblastoma cell lines, SHEP-SF (Figure 1B), with
three of the other cell lines, IMR-5, SH-SY5Y and KCN having
completely lost expression. In contrast, all five medulloblastoma
cell lines retain expression of Par-4 (Figure 1A) and also DAP
(death associated protein) kinase (data not shown). 
Transient over-expression of a constitutively 
pro-apoptotic mutant of Dlk/ZIP kinase induces
apoptosis in D-283 medulloblastoma cells 
Dlk/ZIP kinase is normally localized in the nucleus where it
partially associates with PML (promyelocytic leukaemia) bodies
(Kögel et al, 1999). Transient overexpression of wild type Dlk/ZIP
kinase fused to GFP in D-283 cells revealed the typical speckled
nuclear fluorescence, while a kinase negative mutant, GFP-K42A
was diffusely distributed in the nucleus (Figure 2) as observed
previously in rat fibroblasts (Kögel et al, 1999). Wild type GFP-
Dlk/ZIP kinase alone does not induce apoptosis to a significant
extent. However, coexpression of Dlk/ZIP kinase and Par-4 leads to
cytoplasmic retention of Dlk/ZIP kinase and apoptosis (Page et al,
1999b). In addition, a deletion mutant, GFP-∆ C2 which is lacking
the functional NLS of Dlk/ZIP kinase and consequently is located in
the cytoplasm induces apoptosis with high efficiency (Kögel et al,
1999). GFP-∆ C2 does not require complex formation with Par-4 for
induction of apoptosis but otherwise mimicks all events that occur in
Dlk-Par-4-mediated apoptosis (Kögel et al, 1999; Page et al, 1999a).
Therefore, GFP-∆ C2 represents a constitutively pro-apoptotic
mutant of Dlk/ZIP kinase. Expression of GFP-∆ C2 in D-283 cells
potently induced apoptosis (Figure 2). Based on morphological
criteria, apoptosis triggered by Dlk/ZIP kinase was divided into
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GFP-Dlk wt 24 h GFP-K42A 24 h
GFP-∆ C2 16 h GFP-∆ C2 24 h
Figure 2 DIk/ZIP kinase-induced apoptosis in human D-283 medulloblastoma cells can be divided into distinct stages. D-283 SFFV cells were transiently
transfected with plasmids encoding GFP fusion proteins of DIk/ZIP kinase. Wild type DIk/ZIP kinase (GFP-DIk-wt) and kinase negative mutant K42A (GFP-K42A)
are localized in the nucleus and do not trigger apoptosis. Constitutively pro-apotpotic mutant GFP-∆ C2 induces an early membrane blebbing stage and a late
apoptotic stage (right panel). Live cells were analyzed by epifluorescence microscopy after 16 and 24 h and digital images were acquired. Scale bar = 25 µ m three distinct stages: in stage I, the cells reveal no morphological
signs of apoptosis, stage II is characterized by extensive membrane
blebbing without significant reduction of cell volume, while in 
stage III the cells have ceased blebbing, were drastically shrunken,
detached or even disrupted into apoptotic bodies. 
Bcl-xL inhibits cytochrome c release and late stage
Dlk/ZIP kinase-mediated apoptosis, but does not
abrogate Dlk-induced membrane blebbing 
To analyse the involvement of mitochondrial events in Dlk/ZIP
kinase-mediated apoptosis we employed cell lines D-283 SFFV
and D-283 bcl-xL the latter stably over-expressing the antiapop-
totic bcl-2 family member Bcl-xL (Poppe et al, 2001). Although
overexpression of GFP-∆ C2 in D-283 bcl-xL cells also lead to
extensive membrane blebbing, the majority of cells did not
proceed to the late stage of Dlk/ZIP kinase-mediated apoptosis
(Figure 3A, right panels). Figures 3B and C show the quantifica-
tion of apoptosis stage distribution from three independent experi-
ments (per treatment) after 24 h and 42 h, respectively. Late stage
apoptosis was observed in 51 +/– 4% (after 24 h) and 91+/– 2%
(after 42 h) of D-283 SFFV cells expressing GFP-∆ C2. In contrast,
overexpression of Bcl-xL led to late stage apoptosis in only 
9 +/– 3% (after 24 h) and 28 +/– 12% (after 42 h) of GFP-∆ C2-
expressing cells. Thus, Bcl-xL overexpression arrests the cells
in the membrane blebbing stage by inhibiting the transition from
the early stage to the late stage of Dlk/ZIP kinase-mediated
apotosis. 
The fact that Bcl-xL overexpression inhibited late stage Dlk/ZIP
kinase-mediated apoptosis implied that a mitochondrial step
played a crucial role downstream of Dlk/ZIP kinase activity. Indeed,
Dlk/ZIP kinase-mediated apoptosis triggered by mutant GFP-∆ C2
was associated with release of cytochrome c from the mitochon-
dria as indicated by a diffuse cytoplasmic and nuclear staining
in late stage apoptotic D-283 SFFV cells (Figures 4A and B).
A similar immunofluorescence pattern was observed in cells
transfected with GFP-Bax. Over-expression of GFP-Bax was
sufficent to induce apoptosis without any additional apoptotic
stimulus and the GFP-Bax signal was clustered in the perinuclear
area indicative of mitochondrial localization (Figures 4E and F).
Bcl-xL overexpression inhibited cytochrome c release induced by
GFP-∆ C2 (Figure 4G and H). In cells transfected with GFP-Bax,
overexpression of Bcl-xL blocked cytochrome c release as well
as translocation of GFP-Bax to the mitochondria, as indicated by
the diffuse distribution of the GFP-Bax fluorescence (Figures 4I
and J). 
Dlk/ZIP kinase-mediated apotosis proceeds in the
presence of caspase inhibition 
Addition of the broad range caspase inhibitor zVAD-fmk also
delayed apoptosis triggered by GFP-∆ C2 in D-283-SFFV cells,
but to a much lesser extent than Bcl-xL overexpression. 41 +/– 7
and 63 +/– 10% of GFP-positive cells were in the late stage after
24 h and 42 h, respectively (Figures 3B and C). Treatment of 
D-283 bcl-xL cells with zVAD-fmk did not lead to a synergistic
protection against Dlk/ZIP kinase mediated apoptosis. The apop-
tosis stage distribution of D-283 SFFV cells was also quantified
42 h after transfection in the presence of caspase inhibitors 
Ac-DEVD-CHO and Ac-YVAD-CHO (Figure 5). Treatment
with Ac-DEVD-CHO which inhibits Casp3, Casp7 and Casp8,
but also Casp1, Casp6, Casp9 and Casp10 decreased the amount
of cells in the late stage of apoptosis from 87 +/– 4% (control,
without inhibitor) to 70 +/– 8%. Finally, treatment with Ac-
YVAD-CHO which inhibits Casp1, Casp4 and Casp5 had no
effect at all on apoptosis stage distribution (85 +/– 7% of cells
in the late stage). However, we did not observe disruption of
cells into apoptotic bodies in the presence of either zVAD-fmk
(Figure 2A, middle panels) or Ac-DEVD-CHO (data not shown).
Taken together, these results suggest that caspase activation is
not required for entry into stage III but for late executionary
processes during Dlk/ZIP kinase-mediated apoptosis. 
DISCUSSION 
The present study demonstrates that Dlk/ZIP kinase expression is
retained in medulloblastoma and neuroblastoma cell lines.
The proapoptotic activity of Dlk/ZIP kinase has been suggested
to require complex formation with the early apoptosis response
factor Par-4 and retargeting of this complex to the cytoskeleton
(Page et al, 1999a, b). There is emerging evidence that Par-4
is critically involved in neuronal apoptosis (Mattson et al, 1999).
Interestingly, expression of Par-4 is lost in three of seven
neuroblastoma cell lines investigated, IMR-5, SH-SY5Y and
KCN (Figure 1). Par-4 upregulation is a very early event during
apoptosis and precedes caspase activation and mitochondrial
dysfunction (Guo et al, 1999). In addition to activation of Dlk/ZIP
kinase, Par-4 promotes apoptosis by inhibiting the antiapoptotic
NF-κ B pathway. This is achieved by binding of Par-4 to another
protein kinase, the NF-κ B upstream activator PKCζ (Berra et al,
1997; Diaz-Meco et al, 1999; Camandola and Mattson, 2000).
Thus, Par-4 may represent a central coordinator during the
early stages of apoptosis, which is capable of integrating different
pro-(Dlk/ZIP kinase) and anti-apoptotic (NF-κ B) signalling
pathways by complexing individual components of these path-
ways. 
Dlk/ZIP kinase-induced cell death involves the activation of 
the evolutionarily conserved apoptotic cell death machinery,
comprising cytochrome c release, caspase activation, as well as
cell death regulation by anti-apoptotic Bcl-2 family proteins.
Over-expression of Bcl-xL efficiently blocked cytochrome c
release and late stage apoptosis. In addition, over-expression of
Bcl-2 has been shown to rescue cell death induced by activated
DAP kinase (Cohen et al, 1999). Pro-apoptotic signalling of DAP
kinase family members may generally require the activation of
the mitochondrial apoptosis pathway. In contrast to Bcl-xL over-
expression, caspase inhibition just delayed the progression of
cells from the early to the late stage of Dlk/ZIP kinase-mediated
apoptosis. This suggests that Dlk/ZIP kinase also induced Bcl-xL-
sensitive, but caspase-independent cell death pathways. Indeed, 
it is well-established that programmed cell death can occur in
the absence of caspase activity (Borner and Monney, 1999).
Antiapoptotic bcl-2 family members are capable of blocking
several cell death pathways induced by selective mitochondrial
outer membrane permeabilization during apoptosis. Following
permeabilization of the mitochondrial membrane, a variety of
proapoptotic factors are released that could trigger apoptosis.
Nuclear chromatin condensation induced by the mitochondrial
release of AIF has been shown to occur in a caspase-independent
fashion (Daugas et al, 2000). Furthermore, release of cytochrome
c may lead to an increased generation of reactive oxygen species
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Figure 3 A Late stage apoptosis induced by DIk/ZIP kinase is inhibited by Bcl-xL. Deletion mutant GFP-∆ C2 was transiently transfected into cell lines D-283
SFFV (stably transfected with parental vector pSFFV, left and middle panels) and D-283 bcl-xL (stably over-expressing Bcl-xL, right panels) by lipofection.
Where indicated, broad range caspase inhibitor zVAD-fmk was added to a final concentration of 100 µ M immediately after removal of the transfection
supernatant. Live cells were analysed by epifluorescence microscopy after 24 and 42 h and digital images were acquired. Scale bar = 25 µ m. B and C
Quantitative analysis of apoptosis stage distribution in cell lines D-283 SFFV and D-283 bcl-xL transfected with DIk/ZIP kinase deletion mutant GFP-∆ C2. Each
column represents one individual experiment. After 24 (B) and 42 (C) h, 100 GFP-positive cells per single experiment were counted for apoptotic morphology
using epifluorescence microscopy. Where indicated, broad range caspase inhibitor zVAD-fmk was added to a final concentration of 100 µ M. Experiments were
repeated three times with comparable results 1806 D Kögel et al 
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Figure 4 Late stage DIk/ZIP kinase-mediated apoptosis is associated with release of cytochrome c from the mitochondria. Cell lines D-283 SFFV (A to F) and
D-283 bcl-xL (G to J) were transienty transfected with the indicated GFP-constructs and the cells were fixed after 24 h. Subcellular distribution of cytochrome c
was investigated by immunofluorescence analysis and images of representative cells were acquired. Scale bar = 25 µ m 
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Cyt.c(ROS) during apoptosis (Loeffler and Kroemer, 2000; Luetjens
et al, 2000). It is conceivable that generation of ROS and release
of AIF from the mitochondria are involved in apoptosis triggered
by DAP kinase family members. The nuclear apoptosis regulator
PML has also been implicated in caspase-independent cell death
pathways (Quignon et al, 1998; Guo et al, 2000). Interestingly,
nuclear Dlk/ZIP kinase colocalizes with PML bodies (Kögel et al,
1999), but the significance of this association is unclear at
present. 
Even though Bcl-xL over-expression inhibited late stage apop-
tosis induced by Dlk/ZIP kinase, it had no effect on Dlk/ZIP
kinase-triggered membrane blebbing. Protection by Bcl-xL thus
occured downstream or independent of the initial membrane bleb-
bing step. Hence, Dlk/ZIP kinase likely activates alternative
biochemical pathways responsible for morphological changes
during apoptosis. Dlk/ZIP kinase induces significant membrane
blebbing in cells (Kögel et al, 1999). Membrane blebbing is
considered a hallmark of extranuclear apoptosis and an early
event in apoptotic cell death (Mills et al, 1999). Two recent
reports identified ROCK I as a caspase-dependent effector of
apoptotic membrane blebbing (Coleman et al, 2001, Sebbagh et
al, 2001). However, membrane blebbing has been shown to be
caspase-independent in several apoptotic systems (McCarthy
et al, 1999; Mills et al, 1998). Likewise, membrane blebbing
induced by Dlk/ZIP kinase was neither inhibited by Bcl-xL, nor
by the broad spectrum caspase inhibitor zVAD-fmk. Myosin light
chain (MLC) phosphorylation has been implicated as a critical
event in apoptotic membrane blebbing (Mills et al, 1998;
Coleman et al, 2001; Sebbagh et al, 2001). Interestingly, DAP
kinase family members share high sequence homology with MLC
kinases and several members, including Dlk/ZIP kinase have been
shown to phosphorylate MLC in vitro (Kögel et al, 1998; Murata-
Hori et al, 1999). Thus, DAP kinase family members are likely
candidates for cytoplasmic effectors of apoptotic membrane
blebbing. 
Loss of DAP kinase expression has been shown in a variety of
human tumours (reviewed in Cohen and Kimchi, 2001). In addi-
tion, DAP kinase family members might be inactivated on the
posttranslational level, either by absence of coactivators such
as Par-4 or by anti-apoptotic antagonizers such as Bcl-xL.
Interestingly, basal expression of Par-4 was lost in three of seven
neuroblastoma cell lines investigated. Inactivation of DAP kinase
family members might be critically involved in tumorigenesis and
metastasis of neural tumors. 
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